Guilin Sanjin(SZ:002275) Xin Lang Cai Jing·2025-09-04 08:43Core Viewpoint - Guilin Sanjin Pharmaceutical Co., Ltd. has provided a joint liability guarantee for its wholly-owned subsidiary, Baoshuan Biopharmaceutical Technology (Shanghai) Co., Ltd., amounting to 20 million yuan, with a guarantee period from August 12, 2025, to August 12, 2028 [1] Group 1 - The company has approved a new guarantee limit of up to 270 million yuan for Baoshuan Biopharmaceutical in April and May 2025, and this guarantee falls within the expected limit [1] - The guarantee balance for Baoshuan Biopharmaceutical before this guarantee was 75.7 million yuan, which will increase to 95.7 million yuan after this guarantee, leaving a remaining available limit of 20 million yuan [1] - As of the announcement date, the actual guarantee balance for the company and its subsidiaries is 300.6 million yuan, accounting for 9.99% of the most recent audited net assets [1]